G. Bollard

Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen

A. Schwarer, A. Spencer, J. Muirhead, 2005, Bone Marrow Transplantation.

Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma.

A. Schwarer, D. Hiwase, J. Muirhead, 2007, Cytotherapy.

Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.

A. Schwarer, D. Hiwase, M. Bailey, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up of a pilot study using a chemotherapy-alone protocol for killer Ig-like receptor-ligand-mismatched haploidentical haematopoietic SCT

A. Schwarer, J. Muirhead, C. Hart, 2011, Bone Marrow Transplantation.

The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma.

A. Schwarer, D. Hiwase, M. Bailey, 2008, Cytotherapy.